Publication | Closed Access

A three-drug nanoscale drug delivery system designed for preferential lymphatic uptake for the treatment of metastatic melanoma

NanoparticlesNanomedicineCell-based Drug DeliveryEngineeringMedicineTargeted Drug DeliveryMetastatic MelanomaDrug Delivery SystemsNano-drug DeliveryBiomedical EngineeringDrug Delivery SystemPharmacologyPreferential Lymphatic UptakeTumor Microenvironment